Open AccessHow Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings?
Author(s) -
Thomas S. Harrison,
David S. Lawrence,
Henry C. Mwandumba,
David R. Boulware,
Mina C. Hosseinipour,
Olivier Lortholary,
Graeme Meintjes,
Mosepele Mosepele,
Joseph N Jarvis
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac792
Subject(s) - flucytosine , regimen , amphotericin b , medicine , adverse effect , fluconazole , human immunodeficiency virus (hiv) , cryptococcal meningitis , amphotericin b deoxycholate , intensive care medicine , immunology , antifungal , viral disease , dermatology , caspofungin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom